Volume 3; Issue 7

Nature Reviews Drug Discovery

Volume 3; Issue 7
1

CANCER

Year:
2004
Language:
english
File:
PDF, 668 KB
english, 2004
2

CARDIOLOGY AND VASCULAR DISORDERS

Year:
2004
Language:
english
File:
PDF, 193 KB
english, 2004
3

IMMUNE AND INFLAMMATORY DISORDERS

Year:
2004
Language:
english
File:
PDF, 181 KB
english, 2004
4

INFECTIOUS DISEASES

Year:
2004
Language:
english
File:
PDF, 484 KB
english, 2004
5

METABOLIC AND OTHER DISORDERS

Year:
2004
Language:
english
File:
PDF, 162 KB
english, 2004
8

From the analyst's couch: Targeted lung cancer therapies

Year:
2004
Language:
english
File:
PDF, 117 KB
english, 2004
9

Fresh from the pipeline: Cetuximab

Year:
2004
Language:
english
File:
PDF, 101 KB
english, 2004
10

Establishing novelty and relevant prior art

Year:
2004
Language:
english
File:
PDF, 52 KB
english, 2004
11

High-throughput screening: Free your assay

Year:
2004
Language:
english
File:
PDF, 205 KB
english, 2004
12

New instructions for old invention not patentable

Year:
2004
Language:
english
File:
PDF, 72 KB
english, 2004
13

Prior art

Year:
2004
Language:
english
File:
PDF, 72 KB
english, 2004
14

In Brief

Year:
2004
Language:
english
File:
PDF, 117 KB
english, 2004
15

Structural biology: Not so crystal clear

Year:
2004
Language:
english
File:
PDF, 284 KB
english, 2004
16

Not for sale...yet

Year:
2004
Language:
english
File:
PDF, 72 KB
english, 2004
17

Robert S. Langer

Year:
2004
Language:
english
File:
PDF, 55 KB
english, 2004
18

The genomics evolution

Year:
2004
Language:
english
File:
PDF, 61 KB
english, 2004
19

Muscular dystrophy: A LARGE dose of sugar

Year:
2004
Language:
english
File:
PDF, 284 KB
english, 2004
20

Kinases: Overcoming inhibition

Year:
2004
Language:
english
File:
PDF, 93 KB
english, 2004
21

G-protein-coupled receptors: the devil is in the detail

Year:
2004
Language:
english
File:
PDF, 41 KB
english, 2004
22

THE STATE OF GPCR RESEARCH IN 2004

Year:
2004
Language:
english
File:
PDF, 1.06 MB
english, 2004
23

Cardioprotection: All roads lead to GSK-3β

Year:
2004
Language:
english
File:
PDF, 117 KB
english, 2004
24

How academia can help drug discovery

Year:
2004
Language:
english
File:
PDF, 81 KB
english, 2004
25

Merck's statin first to receive over-the-counter status

Year:
2004
Language:
english
File:
PDF, 123 KB
english, 2004
26

Lessons learnt from Genasense's failure

Year:
2004
Language:
english
File:
PDF, 123 KB
english, 2004
27

News In Brief

Year:
2004
Language:
english
File:
PDF, 65 KB
english, 2004
28

INTRODUCTION

Year:
2004
Language:
english
File:
PDF, 50 KB
english, 2004
29

Reviews and comment from the nature publishing group

Year:
2004
File:
PDF, 34 KB
2004
30

Reviews and comment from the nature publishing group

Year:
2004
File:
PDF, 34 KB
2004